nelfinavir has been researched along with je 2147 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blum, LE; Clemente, JC; Dunn, BM; Goodenow, MM; Hemrajani, R | 1 |
Agbandje-McKenna, M; Clemente, JC; Dunn, BM; Goodenow, MM; Govindasamy, L; Hemrajani, R; McKenna, R; Moose, RE; Reutzel, R; Whitford, LR | 1 |
Hayashi, H; Mimoto, T; Nojima, S; Shintani, M; Takaku, H; Terashima, K | 1 |
3 other study(ies) available for nelfinavir and je 2147
Article | Year |
---|---|
Secondary mutations M36I and A71V in the human immunodeficiency virus type 1 protease can provide an advantage for the emergence of the primary mutation D30N.
Topics: Alanine; Anti-HIV Agents; Asparagine; Aspartic Acid; Binding Sites; Drug Resistance, Viral; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Isoleucine; Kinetics; Methionine; Mutagenesis, Site-Directed; Nelfinavir; Ritonavir; Valine | 2003 |
Comparing the accumulation of active- and nonactive-site mutations in the HIV-1 protease.
Topics: Binding Sites; Crystallography, X-Ray; Dimerization; HIV Protease; HIV Protease Inhibitors; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Indinavir; Kinetics; Models, Molecular; Molecular Structure; Mutation; Protein Structure, Tertiary; Thermodynamics | 2004 |
Structure-activity relationships of novel HIV-1 protease inhibitors containing the 3-amino-2-chlorobenzoyl-allophenylnorstatine structure.
Topics: Animals; Dogs; Drug Design; Hepatocytes; HIV Protease Inhibitors; HIV-1; Humans; Molecular Structure; Mutation; Phenylbutyrates; Sensitivity and Specificity; Structure-Activity Relationship | 2008 |